Reaction
Mycosis Fungoides reporting signals
As of the last recalculation, Mycosis Fungoides appears in 823 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is BRENTUXIMAB VEDOTIN (PRR 55.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Brentuximab Vedotin | 22 | 55.7 | 55.9 |
| Efavirenz | 6 | 13.7 | 13.7 |
| Gemcitabine | 20 | 13.1 | 13.1 |
| Gemcitabine Hydrochloride | 24 | 11.8 | 11.8 |
| Vemurafenib | 5 | 10.6 | 10.6 |